| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 03/21/2002 | US20020034741 Utilization of preferential peptide for the treatment of wounds and gastrointestinal disorders; wound healing agents |
| 03/21/2002 | US20020034563 Process for the production of juices from fruits and vegetables |
| 03/21/2002 | US20020034549 And plasticizer; for pharmaceutical dosage forms, food and confectionery tablets, seeds and granule cores |
| 03/21/2002 | DE10136987A1 Für das clpC-Gen kodierende Nukleotidsequenzen For the CLPC gene coding nucleotide sequences |
| 03/21/2002 | DE10136986A1 New cysD, N, K, E and H genes from coryneform bacteria, useful, when over expressed, for increasing fermentative production of L-amino acids |
| 03/21/2002 | DE10136985A1 Für das gap2-Gen kodierende Nukleotidsequenzen For the gap2 gene coding nucleotide sequences |
| 03/21/2002 | DE10112105A1 Neue für das luxS-Gen kodierende Nukleotidsequenzen New coding for the luxS gene nucleotide sequences |
| 03/21/2002 | DE10109022A1 Neue für das chrS-Gen kodierende Nukleotidsequenzen New coding for the CHRS gene nucleotide sequences |
| 03/21/2002 | DE10044681A1 New L-lactate dehydrogenase gene from coryneform bacteria, useful, when overexpressed, for increasing fermentative production of L-amino acid |
| 03/21/2002 | DE10044325A1 Neue MMP-2-Derivate als Inhibitoren des Integrins avbeta3 New MMP-2 derivatives as inhibitors of the integrin avbeta3 |
| 03/21/2002 | CA2585083A1 Directed evolution method |
| 03/21/2002 | CA2422603A1 Vectors for molecule delivery to cd11b expressing cells |
| 03/21/2002 | CA2422229A1 Calcium binding proteins |
| 03/21/2002 | CA2422163A1 Isolated human kinase proteins, nucleic acid molecules and uses thereof |
| 03/21/2002 | CA2422053A1 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
| 03/21/2002 | CA2421963A1 Directed evolution method |
| 03/21/2002 | CA2421836A1 Pest control system |
| 03/21/2002 | CA2420892A1 Human coagulation factor vii variants |
| 03/21/2002 | CA2418724A1 Target activated nucleic acid biosensor and methods of using same |
| 03/20/2002 | EP1188838A1 Method for producing 7-aminodesacetoxycephalosporanic acid (7-adca) |
| 03/20/2002 | EP1188826A2 5-substituted hydantoin racemase, DNA coding for the same, and process for producing optically active amino acids |
| 03/20/2002 | EP1188823A1 Transformed microorganism and process for producing d-aminoacylase |
| 03/20/2002 | EP1188822A1 L-amino acid-producing bacteria and process for producing l-amino acid |
| 03/20/2002 | EP1188446A1 Proteinaceous vectors for molecule delivery to CD11b expressing cells |
| 03/20/2002 | EP1187938A1 Method of transposon-mediated mutagenesis in the nematode caenorhabditis elegans |
| 03/20/2002 | EP1187936A2 Automatable rapid test for detecting cancers, on the basis of telomerase(htc) mrna and specific primers and probes |
| 03/20/2002 | EP1187925A1 Pectate lyase fusion for expression and secretion of polypeptides |
| 03/20/2002 | EP1187924A1 Substrate trapping protein tyrosine phosphatases |
| 03/20/2002 | EP1187922A2 Pesticidal proteins |
| 03/20/2002 | EP1187911A2 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt |
| 03/20/2002 | EP1187910A1 Methods for enhancing plant defense |
| 03/20/2002 | EP1187899A1 Method and composition for enhancing the activity of an enzyme |
| 03/20/2002 | EP1187844A1 Human carbamyl phosphate synthetase i polymorphism and diagnostic and therapeutic methods relating thereto |
| 03/20/2002 | EP0868503B1 Enzymatic detergent compositions |
| 03/20/2002 | EP0787230B1 Bleaching process comprising use of a phenol oxidizing enzyme, a hydrogen peroxide source and an enhancing agent |
| 03/20/2002 | EP0647710B1 Novel protease |
| 03/20/2002 | EP0642351B1 New pharmaceutical uses of krill enzymes |
| 03/20/2002 | EP0610475B1 Nerve-derived transglutaminase enzyme useful for inducing nerve regeneration |
| 03/20/2002 | EP0589961B1 Assay systems for neurotrophin activity |
| 03/20/2002 | CN1341180A Multi-component system for the enzyme-catalysed oxidation of substrates and method for carrying out enzyme-catalysed oxidation |
| 03/20/2002 | CN1341149A Oxaloacetae hydrolase deficient fungal host cells |
| 03/20/2002 | CN1341148A Nucleic acid molecules encoding alternansucrase |
| 03/20/2002 | CN1341126A Sulfated fucogalactan |
| 03/20/2002 | CN1341028A New use of melagatran |
| 03/20/2002 | CN1340628A Improved method for biological production of carotenoid and its used biomaterial |
| 03/20/2002 | CN1340624A Polypeptide-human cathepsin 10.12 and polynucleotide for coding it |
| 03/20/2002 | CN1340623A Polypeptide-glycosyl hydrolase 33.55 and polynucleotide for coding it |
| 03/20/2002 | CN1340622A Polypeptide-serine/threonine protein kinase MO1511.11 and polynucleotide for coding it |
| 03/20/2002 | CN1340621A Polypeptide-human casein kinase II alpha subunit 22.44 and polynucleotide for coding it |
| 03/20/2002 | CN1340620A Polypeptide-human phosphoryl choline/ethanolamine transferase 22.99 and polynucleotide for coding it |
| 03/20/2002 | CN1340619A Polypeptide-hydrogenase 9.13 and polynucleotide for coding it |
| 03/20/2002 | CN1340618A Polypeptide-nucleotide reductase 13.31 and polynucleotide for coding it |
| 03/20/2002 | CN1340617A Polypeptide-phosphoribosyl glycinamide synthetase 26.39 and polynucleotide for coding it |
| 03/20/2002 | CN1340616A Polypeptide-human fructose-6-phosphate, 2-kinase/fructose-2,6-diphosphatase 14.08 and polynucleotide for coding it |
| 03/20/2002 | CN1340615A Polypeptide-human uracil mononucleotide synthetase 42.79 and polynucleotide for coding it |
| 03/20/2002 | CN1340612A Process for preparing pectinase |
| 03/20/2002 | CN1340304A Feed enzyme and its preparing process |
| 03/19/2002 | US6359197 Regulatory sequences for use in delaying leaf aging in plants |
| 03/19/2002 | US6359196 Regulatory sequences for generating genetic engineered plants for use in malting and steeping |
| 03/19/2002 | US6359194 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 03/19/2002 | US6359193 Nucleotide sequences of lats genes |
| 03/19/2002 | US6359127 Oligonucleotide for use in treatment of cancer and nervous system disorders |
| 03/19/2002 | US6359118 Carbohydrate crosslinked glycoprotein crystals |
| 03/19/2002 | US6359115 Human receptor tyrosine kinase, KDR |
| 03/19/2002 | US6359031 Forming water in oil dispersion of aqueous core comprising core material and reactant in water immiscible liquid which contains an oil soluble or oil swellable polymeric stabiliser, blending dispersion to form shell |
| 03/19/2002 | US6358934 Administering viricide to treat human t-cell leukemia/lymphoma and hepatitis virus infections; acquired immunodeficiency syndrome (aids) treatment |
| 03/19/2002 | US6358931 Oligonucletide conjugated to imidazole; intercalation and coordination compounds; medical diagnosis, gene therapy; antisense agents |
| 03/19/2002 | US6358739 Transiently immortalized cells |
| 03/19/2002 | US6358738 Polo box therapeutic compositions, methods, and uses therefor |
| 03/19/2002 | US6358728 Nucleotide sequences enzymatic polypeptide for use in treatment of vision defects |
| 03/19/2002 | US6358726 Enzymatic polypeptide for use as tools in genetic engineering |
| 03/19/2002 | US6358725 Mouse aspartic secretase-1 (mASP1) |
| 03/19/2002 | US6358724 Enzymatic polypeptide; for use in evaluating carbohydrate structure |
| 03/19/2002 | US6358723 Deoxyribonuclease IIβ proteins and cDNAs |
| 03/19/2002 | US6358722 Genetically engineered polypeptide; for use animal feeds |
| 03/19/2002 | US6358721 Human p101 regulatory polypeptide |
| 03/19/2002 | US6358720 Serine/theonine protein kinase |
| 03/19/2002 | US6358718 Method for stabilization and renaturation of proteins using nucleolar protein B23 |
| 03/19/2002 | US6358716 Method for the production of glycerol by recombinant organisms |
| 03/19/2002 | US6358714 Generation of preferential amino acid in culture; obtain microoganism, transform, culture in nutrient broth, recover phenylalanine |
| 03/19/2002 | US6358709 End selection in directed evolution |
| 03/19/2002 | CA2180024C Dna chain useful for xanthophyll synthesis and process for producing xanthophylls |
| 03/19/2002 | CA2131316C A thrombin blood fraction for use in a medical procedure |
| 03/19/2002 | CA2008390C Mutants of human antithrombin iii |
| 03/14/2002 | WO2002021098A2 A method for identifying polymorphisms |
| 03/14/2002 | WO2002020848A2 Gene and sequence variation associated with cancer |
| 03/14/2002 | WO2002020847A2 Gene and sequence variation associated with lipid disorder |
| 03/14/2002 | WO2002020826A2 An electronic database of enzyme substrate and enzyme inhibitor structures |
| 03/14/2002 | WO2002020818A1 Enhanced in vitro synthesis of active proteins containing disulfide bonds |
| 03/14/2002 | WO2002020815A2 Production of cyclic terpenoids |
| 03/14/2002 | WO2002020813A2 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
| 03/14/2002 | WO2002020812A1 Genetic engineering of syringyl-enriched lignin in plants |
| 03/14/2002 | WO2002020808A1 Isozymes of lacrimator component synthase and gene encoding the same |
| 03/14/2002 | WO2002020807A1 L-methionine $g(g)-lyase with modified function |
| 03/14/2002 | WO2002020806A1 Nucleotide sequences which code for the sahh gene |
| 03/14/2002 | WO2002020805A2 Regulation of human carboxypeptidase-like enzyme |
| 03/14/2002 | WO2002020804A1 Rat cathepsin, dipeptidyl peptidase i (dppi): crystal structure, inhibitors and its uses |
| 03/14/2002 | WO2002020802A1 A cell line expressing mutant human tissue-type plasminogen activator, constructing strategy and method of expressed protein preparation |
| 03/14/2002 | WO2002020801A2 26199, 33530, 33949, 47148, 50226, and 58764, human transferase family members and uses therefor |
| 03/14/2002 | WO2002020800A2 16658, 14223, and 16002, NOVEL HUMAN KINASES AND USES THEREFOR |